SYMPOSIUM ON EBV AND ASSOCIATED DISEASES

EBV 及相关疾病研讨会

• 批准号: 3434140
• 负责人: GARY R. PEARSON
• 金额: $ 0.4万
• 依托单位: GEORGETOWN UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1990
• 资助国家: 美国
• 起止时间: 1990-08-01 至 1991-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3434140
• 关键词: AIDS; B lymphocyte; Burkitt's lymphoma; Epstein Barr virus; Herpesviridae disease; Taiwan; epidemiology; lymphoma; nasopharyngeal neoplasms; travel; viral carcinogenesis

The Epstein-Barr virus (EBV) has been studied extensively for over 25 years as a candidate human cancer virus. The data accumulated until now strongly implicates EBV as a major factor in the etiology of nasopharyngeal carcinoma, African Burkitt's lymphoma and B-cell lymphomas in immunodeficient populations such as transplant patients or individuals with AIDS. Because of this, EBV continues to be of interest to both basic and clinical investigators throughout the world. This is truly an international virus. Recently, major advances from both basic and clinical studies on this virus have been presented mainly at a newly organized international symposium designated "International Symposium on EBV and Associated Malignant Diseases". The first symposium was held in Loutraki, Greece in September 1984 and was attended by approximately 100 scientists. Approximately 200 participants attended the second symposium held in October 1986 in St. Petersburg, Florida and over 300 registrants participated in the third symposium held in Rome, Italy in October 1988. The increasing number of participants in these meetings demonstrates the importance of this symposium to individuals studying EBV. The Fourth International Symposium on EBV and Associated Malignant Diseases is scheduled to be held in Hualien, Taiwan from September 23-28, 1990 under the sponsorship of National Taiwan University College of Medicine. This symposium will continue to focus on recent advances on this virus and associated diseases from basic molecular studies to applied studies in a clinical setting. Topics to be discussed at this symposium include sessions on the molecular biology of EBV infections; pathobiology of EBV diseases; immunobiology of EBV infections; and round-table discussions specifically focusing on NPC and EBV associated lymphoproliferation disorders including those that have been identified in AIDS patients. The first Gertrude and Werner Henle Lecture in Viral Oncology will also be presented at this symposium by a major investigator in this area of research. The proceedings of the symposium will be published.

Epstein-Barr 病毒 (EBV) 已被广泛研究超过 25 年 作为候选人类癌症病毒。迄今为止积累的数据强劲 表明 EBV 是鼻咽癌病因的一个主要因素 癌、非洲伯基特淋巴瘤和 B 细胞淋巴瘤 免疫缺陷人群，例如移植患者或患有免疫缺陷的个体 艾滋病。正因为如此，EBV 仍然引起基础和研究人员的兴趣。 世界各地的临床研究人员。这才是真正的国际化 病毒。近年来，基础研究和临床研究均取得重大进展 这种病毒主要是在新组织的国际会议上提出的 研讨会指定为“EBV 及相关国际研讨会” 恶性疾病”。首届研讨会于2017年在希腊路特奇举行 1984 年 9 月，约有 100 名科学家参加。 约 200 名与会者参加了第二届研讨会 1986 年 10 月在佛罗里达州圣彼得堡举行，共有 300 多名注册者 1988年10月参加在意大利罗马举行的第三届研讨会。 参加这些会议的人数不断增加表明 本次研讨会对于研究 EBV 的个人的重要性。第四个 EBV 及相关恶性肿瘤国际研讨会将于 定于1990年9月23日至28日在台湾花莲举行 国立台湾大学医学院赞助。这 研讨会将继续关注该病毒的最新进展以及 相关疾病从基础分子研究到应用研究 临床环境。本次研讨会讨论的主题包括分会场 EBV 感染的分子生物学； EBV疾病的病理学； EBV 感染的免疫生物学；以及具体的圆桌讨论 专注于 NPC 和 EBV 相关的淋巴细胞增殖性疾病，包括 那些已经在艾滋病患者身上发现的。第一个格特鲁德和 Werner Henle 病毒肿瘤学讲座也将在本次会议上进行 由该研究领域的主要研究者举办的研讨会。诉讼程序 会议纪要将予以公布。